Eosinophilic Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA safety_alert · 2014-10-24
European Medicines Agency recommends further measures to minimise risk of blood vessel blockage with Iclusig
EMA recommends additional measures to reduce the risk of blood vessel blockage with Iclusig (ponatinib), a cancer medicine, to improve patie…